title: [Taxol and simultaneous radiotherapy in stage IIIA and IIIB, locally advanced, non-small-cell bronchial carcinoma. Phase-I clinical trial].
authors.affiliation: Strahlentherapie, Städtische Kliniken Offenbach a.M.
authors.forename: H G
authors.initials: HG
authors.lastname: Vogt
authors.forename: C
authors.initials: C
authors.lastname: Kolotas
authors.forename: T
authors.initials: T
authors.lastname: Martin
authors.forename: L V
authors.initials: LV
authors.lastname: Schneider
authors.forename: R
authors.initials: R
authors.lastname: Goes-Schmieder
authors.forename: P S
authors.initials: PS
authors.lastname: Mitrou
authors.forename: H
authors.initials: H
authors.lastname: Kettner
authors.forename: B
authors.initials: B
authors.lastname: Kober
authors.forename: N
authors.initials: N
authors.lastname: Zamboglou
mesh_terms: D000328:Adult; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D011838:Radiation-Sensitizing Agents; D017239:Paclitaxel